ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G Report for ADIAL PHARMACEUTICALS Common stock, par value $0.0001 per share (ADIL)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: ADIAL PHARMACEUTICALS Common stock, par value $0.0001 per share
Symbol: ADIL
Shares outstanding: 28,024,454 shares
Disclosed Ownership: 2,799,643 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 18 Feb 2026, 11:06:49 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	2,799,643	0	2,799,643	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	2,799,643	0	2,799,643	/s/ Steven Boyd	Steven Boyd